Specific gene variants (PAM gene) cause GLP-1 resistance in 1 in 10 people, reducing the efficacy of type 2 diabetes drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results